Development
Microbot Medical Inc.
MBOT
$2.92
$0.051.74%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -26.36% | -11.88% | -0.11% | 6.64% | 16.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.29% | -10.91% | 7.27% | 16.94% | 40.84% |
| Operating Income | 23.29% | 10.91% | -7.27% | -16.94% | -40.84% |
| Income Before Tax | 24.56% | 11.51% | -5.93% | -16.40% | -39.02% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 24.56% | 11.51% | -5.93% | -16.40% | -39.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.56% | 11.51% | -5.93% | -16.40% | -39.02% |
| EBIT | 23.29% | 10.91% | -7.27% | -16.94% | -40.84% |
| EBITDA | 23.50% | 11.14% | -7.10% | -16.82% | -40.76% |
| EPS Basic | 39.10% | 19.73% | -1.31% | -14.30% | -39.02% |
| Normalized Basic EPS | 39.12% | 19.78% | -1.27% | -14.25% | -39.02% |
| EPS Diluted | 39.10% | 19.73% | -1.31% | -14.30% | -39.02% |
| Normalized Diluted EPS | 39.12% | 19.78% | -1.27% | -14.25% | -39.02% |
| Average Basic Shares Outstanding | 28.85% | 12.68% | 5.33% | 2.14% | 0.00% |
| Average Diluted Shares Outstanding | 28.85% | 12.68% | 5.33% | 2.14% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |